L 022 2002 EN 1 1 01 20020124 EN 001 1 1 2 2 <TI> <P> <HT TYPE="UC">Decision of the EEA Joint Committee</HT> </P> <P>No 124/2001</P> <P>of <DATE ISO="20011123">23 November 2001</DATE> </P> <P>amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement</P> </TI> THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as the Agreement, and in particular Article 98 thereof, Whereas: (1) Annex I to the Agreement was amended by Decision of the EEA Joint Committee No 102/2001 of 26 October 2001

OJ L 322, 6.12.2001, p. 6.

. (2) Commission Decision 2000/111/EC of 21 December 1999 designating a new antigen bank and making provisions for the transfer and storage of antigens within the framework of the Community action concerning reserves of foot-and-mouth disease vaccines

OJ L 33, 8.2.2000, p. 19.

 is to incorporated into the Agreement. (3) Commission Decision 2000/112/EC of 14 January 2000 detailing the distribution between antigen banks of antigen reserves established within the framework of the Community action concerning reserves of foot-and-mouth disease vaccines and amending Commission Decisions 93/590/EC and 97/348/EC

OJ L 33, 8.2.2000, p. 21.

 is to be incorporated into the Agreement. (4) Council Decision 2000/258/EC of 20 March 2000 designating a specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines

OJ L 79, 30.3.2000, p. 40.

 is to be incorporated into the Agreement. (5) This Decision is not to apply to Iceland and Liechtenstein, HAS DECIDED AS FOLLOWS
Article 1

Part 3.2 of Chapter I of Annex I to the Agreement shall be amended as follows:

1. The following points shall be inserted after point 11 (Commission Decision 98/502/EC):

12. 32000 D 0111: Commission Decision 2000/111/EC of 21 December 1999 designating a new antigen bank and making provisions for the transfer and storage of antigens within the framework of the Community action concerning reserves of foot-and-mouth disease vaccines (OJ L 33, 8.2.2000, p. 19), 13. 32000 D 0112: Commission Decision 2000/112/EC of 14 January 2000 detailing the distribution between antigen banks of antigen reserves established within the framework of the Community action concerning reserves of foot-and-mouth disease vaccines and amending Commission Decisions 93/590/EC and 97/348/EC (OJ L 33, 8.2.2000, p. 21).

2. The following indent shall be added in point 9 (Commission Decision 93/590/EC):

— 32000 D 0112: Commission Decision 2000/112/EC of 14 January 2000 (OJ L 33, 8.2.2000, p. 21).

Article 2

The following point shall be inserted after point 53 (Commission Decision 2000/171/EC) in Part 4.2 of Chapter I of Annex I to the Agreement:

54. 32000 D 0258: Council Decision 2000/258/EC of 20 March 2000 designating a specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines (OJ L 79, 30.3.2000, p. 40).

Article 3 The texts of Decisions 2000/111/EC, 2000/112/EC and 2000/258/EC in the Norwegian language, to be published in the EEA Supplement to the Official Journal of the European Communities, shall be authentic.
Article 4 This Decision shall enter into force on 24 November 2001, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee

No constitutional requirements indicated.

.
Article 5 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Communities.

Done at Brussels, 23 November 2001.

For the EEA Joint Committee

The President

E. Bull